Today’s digital health solutions can address many of pharma’s most vexing problems, but unfortunately, too many pharma companies haven’t yet realized digital health’s full potential. The industry has learned a lot from its experimentation with digital health, and several trends suggest that digital health overall is reaching a critical inflection point. Increased competition from tech players and startups, and growing support for a range of specific and tangible use cases, also suggest that pharma is getting close to realizing the payoff from digital health.
According to ZS’s digital health team’s research, the potential impact of digital health for pharma represents an eye-opening $100 billion opportunity.
